6533b830fe1ef96bd1296654
RESEARCH PRODUCT
The impact of psychopharmacology on contemporary clinical psychiatry.
Gustavo H. Vázquezsubject
medicine.medical_specialtyCanadaQuality Assurance Health CarePsychopharmacologyAlternative medicineMEDLINEpsychiatric treatmentspsychiatric diagnosisclinical psychiatryPsychiatric educationMedicineHumansPractice Patterns Physicians'PsychiatryRandomized Controlled Trials as TopicPsychiatryClinical psychiatryPsychotropic DrugsPractice patternsbusiness.industryMental DisordersExpert consensusChecklistPsychiatry and Mental healthTreatment OutcomeTolerabilityIn ReviewPsychopharmacologyClinical CompetenceGuideline AdherencebusinessForecastingdescription
Clinical psychiatric evaluations of patients have changed dramatically in recent decades. Both initial assessments and follow-up visits have become brief and superficial, focused on searching for categorical diagnostic criteria from checklists, with limited inquiry into patient-reported symptomatic status and tolerability of treatments. The virtually exclusive therapeutic task has become selecting a plausible psychotropic, usually based on expert consensus guidelines. These guidelines and practice patterns rest mainly on published monotherapy trials that may or may not be applicable to particular patients but are having a profound impact, not only on modern psychiatric practice but also on psychiatric education, research, and theory.
| year | journal | country | edition | language |
|---|---|---|---|---|
| 2014-08-01 | Canadian journal of psychiatry. Revue canadienne de psychiatrie |